Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology/Plastic Surgery | Rheumatology
Disease Category: Psoriasis and Psoriatic Disorders

Trial Information

Opportunity to participate: New Psoriasis Study Being Conducted

Skin Conditions: Must have moderate to severe plaque-type psoriasis.

Name of Medication Being Tested: Etanercept (Enbrel ®)

Criteria Needed to be Entered into Study:

• Children 4 to 17 years of age
• Must have psoriasis for minimum of 6 months
• Minimum 10% of total body surface area of psoriasis
• Must have either one of the following medication history:
  • Have had or currently being treated with medication such as PUVA, UVB, UVA, Methotrexate, Cyclosporine, Retinoids
  • Poorly controlled with certain types of topical psoriasis therapy

Reasons Why You May Not Qualify: Have used Enbrel in the past

Study Specifics:

• 52 to 57 week study with 16 visits
• Study enrollment begins August 2004

If you are interested in receiving more information about this research study or are interested in being involved in the research,

Clinical Partners, LLC
1524 Atwood Ave, Suite #330
Johnston, RI 02919
Phone: 401-454-3800

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.